LPS up-regulated EPCR and TM mRMA expression
| . | WT-Con . | TG-Con . | WT-LPS . | TG-LPS . |
|---|---|---|---|---|
| EPCR, % GAPDH | 119 ± 28 | 88 ± 22 | 863 ± 170* | 189 ± 84*† |
| TM, % GAPDH | 75 ± 12 | 65 ± 7 | 411 ± 170* | 252 ± 74* |
| . | WT-Con . | TG-Con . | WT-LPS . | TG-LPS . |
|---|---|---|---|---|
| EPCR, % GAPDH | 119 ± 28 | 88 ± 22 | 863 ± 170* | 189 ± 84*† |
| TM, % GAPDH | 75 ± 12 | 65 ± 7 | 411 ± 170* | 252 ± 74* |
Kidney was collected at 6 hours after LPS. EPCR and TM mRMA levels were quantified using quantitative RT-PCR and normalized to the level of glyceraldehyde 3-phosphate dehydrogenase (GAPDH) mRNA. Data are mean ± SEM of 8 mice.
P < .01 compared with WT-Con and TG-Con groups.
P < .01 compared with WT-LPS group.